Provecs Medical Overview
- Founded
- 2005

- Status
- Out of Business
- Employees
- 4

- Latest Deal Type
- Out of Business
Provecs Medical General Information
Description
Developer of a proprietary enviro adenoviral platform intended to provide novel treatment options for patients with advanced cancers and infectious diseases. The company's platform leverages technology to develop a versatile and cost-effective platform that locally delivers bio-molecules known to be non-tolerable in systemic use or impossible to manufacture, such as membrane proteins, short-lived cytokines, enabling clients to get access to tumor gene therapy to expose the tumor to the immune system.
Contact Information
- Martinistraße 64
- 20251 Hamburg
- Germany
Provecs Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 01-Aug-2020 | Completed | Out of Business | |||
3. Secondary Transaction - Private | 28-Jul-2015 | Completed | Generating Revenue | |||
2. Angel (individual) | 01-Jan-2010 | Completed | Startup | |||
1. Seed Round | 03-Aug-2007 | Completed | Startup |
Provecs Medical Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial